参考文献/References:
［１］Lin CP，Yu HC，Cheng JS，et al．Clinical effects of intra-arterial infusion chemotherapy with cisplatin，mitomycin C，leucovorin and５-flourouracil for unresectable advanced hepatocellular carcinoma［J］．J Chin Med Assoc，２００４，６７：６０２-６１０．
［２］Kato H，Nagano H，Ota H，et al．Successful treatment of com-bined intraarterial（５-fluorouracil and adriamycin and cisplatin）infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and／or portal vein thrombosis—two case reports［J］．Gan To Kagaku，２００５，３２：１８４２-１８４５．
［３］Lai YC，Shih CY，Jeng CM，et al．Hepatic arterial infusion chemo-therapy for hepatocellular carcinoma with portal vein tumor thrombosis［J］．World J Gastroenterol，２００３，９：２６６６-２６７０．
［４］Yamamoto N，Murata K，Fuka H，et al．Macrocytic anemia dur-ing low-dose cisplatin and５-Fluorouracil through implanted infusion port for unresectable hepatobilliary malignancies［J］．Anticancer Res，２００５，２５：１２４３-１２４６．
［５］钱军．抗癌新药一榄香烯的药理及临床［J］．中国肿瘤临床，１９９６，２３：４５３．
［６］吴伟忠，刘康达，汤晓雷，等．β－榄香烯诱导的抗肿瘤免疫保护作用机理初探［J］．中华肿瘤杂志，１９９９，２１：４０５-４０９．
［７］徐学军，周子成，罗元辉，等．β－榄香烯诱导人肝癌细胞株SMMC-７７２１凋亡的研究［J］．第三军医大学学报，１９９９，４：２６８．
［８］肖立森，朱为民．榄香稀经肝动脉介入治疗原发性肝癌的临床研究总结［J］．中国肿瘤临床，１９９６，２３：７５７-７８５．
［９］陈骏，王峰，杨葆华，等．榄香烯联合介入治疗中晚期肝癌９２例［J］．介入放射学杂志，２００２，１１：２１０-２１２．
［１０］刘雪梅．中药榄香烯乳介入治疗肝癌３０例报告［J］．中国医师杂志，２００２，４：３２９-３３０．
［１１］华阳，李康，李法庆，等．榄香稀乳剂在治疗原发性肝癌介入治疗中的应用［J］．中医药学刊，２００３，２１：３９３．
［１２］梁宇闯，林坚，李卓永，等．经肝动脉插管灌注榄香稀乳剂治疗中晚期肝癌的观察［J］．右江民族医学院学报，２００４，２６：２００-２０１．
相似文献/References:
[1]林宇宁,杨熙章,李惠敏,等.介入栓塞治疗良性肝动脉－门静脉瘘一例[J].介入放射学杂志,2009,(12):957.
LIN Yuning,YANG Xizhang,LI Huimin,et al.Interventional embolization therapy for benign hepatic arterioportal fistulas：report of one case[J].journal interventional radiology,2009,(08):957.